Decoding the brain isn't science fiction—it's the next frontier in medicine.
Paradromics is pushing the boundaries of what's possible with brain-computer interfaces (BCI). In 2015, Founder and CEO Matt Angle recognized that current technologies couldn't provide enough data to truly transform healthcare. While working with clinical researchers who were using early BCI systems to help people with paralysis regain control, Matt realized that decoding significantly more brain data—ten or even one hundred times more—could have a game-changing impact. That's exactly what Paradromics is working to achieve.
Paradromics’ BCI platform records brain activity with unmatched precision, capturing data at the level of individual neurons. This advanced technology enables the decoding of vast amounts of brain data, opening the door to next-generation treatments for paralysis, chronic pain, addiction, mental health conditions, and more. With the power of AI, this platform has the potential to radically shift how healthcare providers approach some of the most challenging medical conditions.
With its first clinical trial approaching, Paradromics is set to change the treatment of neurological conditions for millions.
